Track the 삼일제약 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 삼일제약 has logged 56 public disclosures. The latest transaction was reported on 1 July 2026 (Purchase). Among the most active insiders: 허승범. The full history is free.
55
Insider Decl.
n/a
Thresholds
n/a
35 ops.
Buy Volume
n/a
16 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
삼일제약 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in the research, development, and marketing of pharmaceutical products.